MicroPort Orthopedics said today it launched its Procotyl Prime acetabular cup system.
The Arlington, Tenn.-based company won FDA 510(k) clearance for the system in late June, and said that the system is the next step in the evolution of its Dynasty acetabular cup system.
“At MicroPort Orthopedics, we embrace the constant advance in orthopedic medicine, and have a deep commitment to creating products that make patients’ lives better. The Procotyl Prime acetabular cup system, with its best-in-class features, is a great example of this commitment, as it not only strengthens our position as a leader in surgical joint replacement, but also complements our existing products and surgical approaches to help patients return to full function faster,” prez Aurelio Sahagun said in a press release.
MicroPort Orthopedics touted the Procotyl Prime as the 1st on the market with simple, versatile instrumentation to support a number of surgical approaches.
“Procotyl Prime’s design is a culmination of over 20 years of market experience coupled with intelligent design and engineering. We set out to design an implant optimized for highly-crosslinked polyethylene and modern 3D fixation surfaces, allowing us to eliminate compromises. The result is a shell that is strong and flexible, has maximized poly thickness and robust pull-out strength, all while allowing the versatility of large head options in the smallest sizes,” Dr. James Chow of the Phoenix St. Luke’s Medical Center said in a prepared statement.
“Procotyl Prime is the first acetabular component adapted for MicroPort’s novel portal-assisted acetabular instrumentation. This unique approach facilitates preservation of soft tissue, fast patient recovery, and direct acetabular visualization,” Dr. Brad Penenberg of Cedars-Sinai Hospital said in a prepared release.
In February, MicroPort released the results from a study of its Medial-Pivot knee system, touting high rates of satisfaction and survivorship at 17 years.